".have I left anything out?" Yes--the only thing that actually matters to the common stock:
the burn between here and $1,000 revenue from any of the lab projects.
Which will all be done by dilution.
Send BTX the wt and $5 and they send you a share of stock. Unless BTX is significantly above $5, the warrants are worthless.... unless you are a professional short, in which case they guarantee a limit loss.
iconoclast, "with SOME investigation"??? rotfl.... you found out month old public information understandable by a high schooler. You're in a stiock and don;t reqd 8Ks within an hour of filing? There's a word for that in the trade: roadkill.
Good guess. BTX has already spent a couple million on this or more (it hides such costs in its filings) since Mikey went from being on the BOD to being CEO and the dilution kicked in--and ---what is it? It's a catalog. Take a look at ther line item "sale of research products"---that's what it does. It disintermediates the 50% cut it was paying to others on gross. So: best case analysis, double that line item then have it go up 25% a year compounded. Then guess the year that the revs match up to Mikey's option package.
You mean by having a product other than t-stock that can generate 25% of G&A? It's currently at least 18 mos away---if not 3 years.
Havng proven yourself a punk poser, laughing at you from retirement for the benefits of the newbies who might get sucked into this dog will be enjoyable.
To anybody but a welfare queen, that's high school level work. Go get enough brain cells to learn to read a filing.
When the reail cannon fodder is run by people who think the difference between a blastocyst and a prion has anything to do with revs minus cog or ROI on R&D, then road kill is generated. The kiddieschool attempt at "Jedi mind tricks" evident in spouting off about the "science" is just that--kiddie school.
It's been 30 years since Mikey discovered the telomere. What's the accumulated shareholder deficit from attempts to turn that into revenue fro retail shareholders? THAT number is "science"--the rest is boiler room and P&D, from which a handfull of insiders, cronies, MMs and specialists have skimmed more than enough to make keeping the game going worthwhile.
First acknowledging your intelligence (a rarity around here) whether __anything__ is pointless can by definition have no scientific basis. Science is not a value system, but a method for testing them. Whether 2mm cells is "sufficient" is an opinion. There is no actual data from the 2mm tests to suggest that changing the number will induce desired result---only that there is no indication at all that it will be dangerous, so, hey, maybe worth a try.
So far as the punktailed attempt at snark about " brain cells" you just showed your hand. So far you self-evidendtly demonstrate an absenc of sufficent cells to demonstrate the results I would have expected from a highschool intern: write up the quants.
Nope. It's heading towards 3x par, which is going to rise to near $2. Just look at the "basic stats" page and compare them with anything you own from the S&P, or any "bio" or "health" tickers you own.
The only "concern" to BTX retail holders is that the most recent welfare check scored 71 by CIRM, and represented about 1/2 of the funds that GERN refunded to CIRM when it realised its spinal program was pointless. It then sold about $160mm worth of spending to BTX for a nickel on the $.
"Real" institutional _________investors___________ got into this dog below 3/8, and are at 0 basis long ago. Real wealth mgt houses won;t touch it until it can show how it will bring in enough non-welfare check revenue to make payroll. That's about 3 years out minimum.
Unless, of course, lolol, you can post 200 words or less of actual quant on this dog that doesn't reduce to "Mikey is Mikey, AK is AK--science, stem cells, future, singularity" gablahblah.
Jut an actual write up that meets standards I expected from high school age interns.
" A few previously paralyzed patients walking would cause BTX and ASTY to skyrocket." For 10 days while it was getting pumped by insiders, cronies and professional shorts looking for suckers to sell to.
ips, After 3 years of "Cornell" you still haven't found out how much BTX pays Cornell ever quarter. It's not a "partner"--it's a hired contractor doing work Mikey pretends to know how to do--and it will keep taking the $$ as long as BTX shareholders keep sending it to them.
" attracted to this company because of potential " Potential WHAT? The current "breakthru" is a "me,too" generic surgical jelly that is essentially a chicken fat byproduct. The next headliner will be a redundant blood test getting a "me,too" rating from the FDA against two other competitors. The shareholders who backed one of those two competitors got wiped out.
Fifty per cent of the mkt cap of this dog comes from corspiscle cult koolade drinkers; and another 30% or so comes from big houses getting stuck owning as part of one or another index.
Since you gave no clue about WHY you wouold want to buy BTX now, you can be sure that anyone who says yes is a pumper trying to shaft you.
OK--find the line item for "sale xof research products" from the 10Q. Let it grow 30% a year for 10 years. At that point, it will about equal payroll, with around another $250million in dilution to shareholders, leaving them with 1/2 of what they have now.
And that's the best case scenario.